Health Care • Ophthalmic Goods
$60.34 ▲ +0.93
(+1.57%)
MKT CAP: $11.47B • VOL: 1.76M
52W L $51 52W H $90
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$51
MEDIAN
$68
MEAN
$69
HIGH
$82
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE COO TAPE
COO // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $73.01 | $69.39 | 2025-02-14 | $54.91 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $76.03 | $71.20 | 2025-02-06 | $56.72 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $68.79 | $66.37 | 2025-01-29 | $57.93 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $61.55 | — | 2025-01-17 | $59.13 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $53.10 | $57.32 | 2025-01-09 | $53.70 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $71.80 | $62.75 | 2024-12-18 | $52.50 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $58.53 | $60.94 | 2024-12-04 | $56.12 | -4.3% | 48% | C |